Effect of Polylysine on Scrapie Prion Protein Propagation in Spleen during Asymptomatic Stage of Experimental Prion Disease in Mice |
Titlow, William B.
(Sander-Brown Center on Aging, College of Medicine, University of Kentucky)
Waqas, Muhammad (Department of Pharmacy, College of Pharmacy, Hanyang University) Lee, Jihyun (Department of Pharmacy, College of Pharmacy, Hanyang University) Cho, Jae Youl (Department of Genetic Engineering, Sungkyunkwan University) Lee, Sang Yeol (Department of Life Science, Gachon University) Kim, Dae-Hwan (Institute of Pharmaceutical Technology, Hanyang University) Ryou, Chongsuk (Sander-Brown Center on Aging, College of Medicine, University of Kentucky) |
1 | Beekes M, McBride PA. 2007. The spread of prions through the body in naturally acquired transmissible spongiform encephalopathies. FEBS J. 274: 588-605. DOI |
2 | Bosque PJ, Ryou C, Telling G, Peretz D, Legname G, DeArmond SJ, Prusiner SB. 2002. Prions in skeletal muscle. Proc. Natl. Acad. Sci. USA 99: 3812-3817. DOI |
3 | Grathwohl KU, Horiuchi M, Ishiguro N, Shinagawa M. 1996. Improvement of PrPSc-detection in mouse spleen early at the preclinical stage of scrapie with collagenase-completed tissue homogenization and Sarkosyl-NaCl extraction of PrPSc. Arch. Virol. 141: 1863-1874. DOI |
4 | Ryou C. 2007. Prions and prion diseases: fundamentals and mechanistic details. J. Microbiol. Biotechnol. 17: 1059-1070. |
5 | Jackson KS, Yeom J, Han Y, Bae Y, Ryou C. 2013. Preference toward a polylysine enantiomer in inhibiting prions. Amino Acids 44: 993-1000. DOI |
6 | Lee H-M, Ryou C. 2014. Targeting of poly(L-lysine) to organs that propagate prions. J. Bioactive Compat. Polym. 29: 432-444. DOI |
7 | Prusiner SB. 1998. Prions. Proc. Natl. Acad. Sci. USA 95: 13363-13383. DOI |
8 | Ryou C. 2010. Transmissible spongiform encephalopathy, pp. 151-172. In Saleh M (ed.). Molecular Aspects of Infectious Diseases. Nova Science Publisher, Hauppauge, New York. |
9 | Ryou C. 2011. Prion Diseases. Encyclopedia of Life Sciences, Wiley, Chichester, UK. |
10 | Ryou C, Mays CE. 2010. Prions pp. 129-149. In S al eh M (ed.), Molecular Aspects of Infectious Diseases. Nova Science Publisher, Hauppauge, New York. |
11 | Ryou C, Titlow WB, Mays CE, Bae Y, Kim S. 2011. The suppression of prion propagation using poly-L-lysine by targeting plasminogen that stimulates prion protein conversion. Biomaterials 32: 3141-3149. DOI |
12 | Tatzelt J, Groth DF, Torchia M, Prusiner SB, DeArmond SJ. 1999. Kinetics of prion protein accumulation in the CNS of mice with experimental scrapie. J. Neuropathol. Exp. Neurol. 58: 1244-1249. DOI |
13 | Titlow WB, Lee CH, Ryou C. 2013. Characterization of toxicological properties of L-lysine polymers in CD-1 mice. J. Microbiol. Biotechnol. 23: 1015-1022. DOI |
14 | Trevitt CR, Collinge J. 2006. A systematic review of prion therapeutics in experimental models. Brain 129: 2241-2265. DOI |
![]() |